CRENEZUMAB
UNII O8AS5277H0

Substance Identification & Data

This profile provides standardized clinical and technical data for Crenezumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O8AS5277H0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1095207-05-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O8AS5277H0

CAS Registry Number

1095207-05-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CRENEZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174789

National Cancer Institute reference terminology for clinical and research data.

INN ID

9482

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-113

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Crenezumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CRENEZUMAB

Common Names & Synonyms

CRENEZUMAB [INN]

CRENEZUMAB [JAN]

CRENEZUMAB [USAN]

CRENEZUMAB [WHO-DD]

IMMUNOGLOBULIN G4, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL MABT5102A HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MABT5102A LIGHT CHAIN, DIMER